Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Allakos Stock Is Crashing Today

TheMotleyFool

0 0

Shares of Allakos (NASDAQ: ALLK) are crashing 88% lower as of 10:17 a.m ET on Wednesday. The huge decline came after the company announced results from its phase 3 Enigma 2 and its phase 2/3 Kryptos clinical studies evaluating lirentelimab.

Allakos reported that both clinical studies met their histologic co-primary endpoints. However, neither study achieved statistically significant improvement on patient-reported symptomatic co-primary endpoints.

Image source: Getty Images.

Source Fool.com

Like: 0

ALLK

Share